Phase II randomized, controlled trial of 1 day versus 3 days of dexamethasone combined with palonosetron and aprepitant to prevent nausea and vomiting in Japanese breast cancer patients receiving anthracycline-based chemotherapy
Crossref DOI link: https://doi.org/10.1007/s00520-015-2905-4
Published Online: 2015-09-08
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kosaka, Yoshimasa
Tanino, Hirokazu
Sengoku, Norihiko
Minatani, Naoko
Kikuchi, Mariko
Nishimiya, Hiroshi
Waraya, Mina
Katoh, Hiroshi
Enomoto, Takumo
Sato, Takeo
Kuranami, Masaru
Watanabe, Masahiko
License valid from 2015-09-08